SAIL-0804 shows rapid and deep B cell depletion along with repopulation by mostly immature phenotypes in preclinical models, supporting its advancement into IND-enabling studies Sail Biomedicines, a ...

Company to share updates at the AACR and ASGCT annual meetings BOSTON--(BUSINESS WIRE)--Strand Therapeutics Inc., the programmable mRNA company developing curative therapies for cancer and beyond, ...

Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) grant for her research in synthetic DNA ...

Not only can these particles be transformed into tooth-cleaning shapes, but their action can have antimicrobial effects that destroy plaque-causing bacteria. Share on Facebook (opens in a new window) ...

CLEVELAND—Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) grant for her research in synthetic ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Laura Sepp-Lorenzino, Ph.D., has ...

Researchers led by a team at the University of Waterloo have developed a way to create tiny droplets of one liquid inside another liquid without mixing the two together. The process involves ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...

(Nanowerk Spotlight) Millions of patients who rely on biological medications face a frustrating reality: frequent injections. Modern drugs for conditions from diabetes to arthritis can't be taken as ...